Comparative Treatment Study in Patients With Lower Ureteral Stones
- Conditions
- Urinary Calculi
- Registration Number
- NCT00397397
- Lead Sponsor
- Hillel Yaffe Medical Center
- Brief Summary
We wish to determine the best treatment for expulsion of lower ureteral stones. Which of the three major treatment protocols is the best treatment of conservative management of ureteral stones?
- Detailed Description
The study will include 60 patients with lower ureteral stones. The patients will be divided into three groups. The first group will be administered Alfuzosin (10 mg). The second group will be administered a combination of Alfuzosin (10 mg)and Rowatinex (Pinene 31%, Camphene 15%, Anetol 4%, Borneol 10%, Cineol 3%, Fenchenol 4%, Olive Oil 33%). The third group will be administered Rowatinex.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Clinical diagnosis of lower ureter (urinary calculi) up to 8mm
- Must be able to swallow tablets
Exclusion Criteria
- Sensitivity to Alfuzosin and Rowatinex
- Pregnant and breastfeeding women
- Single kidney
- Obstructing stone
- Renal failure creatinine up to 1.8 mg/dl
- Patients using various alpha blockers
- Liver failure
- Fever higher than 38 C
- UTI
- Syncope or hypotension
- Patients treated with PDE5
- Patients treated with inhibitor CYP3A4
- Patients refusing participation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hillel Yaffe Medical Center
🇮🇱Hadera, Israel